Sumitomo dainippon pharma locations. Sumitomo Pharma has received cond...

Sumitomo dainippon pharma locations. Sumitomo Pharma has received conditional and time-limited approval in Japan to manufacture and market AMCHEPRY, an Oct 21, 2021 · Sumitomo Dainippon Pharma is engaged in the research and development of new pharmaceutical products in the areas of psychiatry and neurology, oncology and cell therapy. View Sumitomo Pharma Co Ltd company headquarters address along with its other key offices and locations. , Ltd. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Sumitomo Pharma Company Limited (住友ファーマ株式会社, Sumitomo Fāma Kabushiki-Gaisha) is a Japanese multinational pharmaceutical company. Office locations The Sumitomo Corporation of Americas Network comprises 8 U. S. is a Japan-based pharmaceutical company headquartered in Osaka that develops, manufactures and markets prescription drugs. 4 days ago · Based on the data from an investigator‑initiated clinical study* 1 conducted by Kyoto University Hospital, Sumitomo Pharma submitted its an application for manufacturing and marketing authorization on August 5, 2025, and has now obtained the conditional and time‑limited approval. The companies initially collaborated in June last year. Sumitomo Dainippon Pharma Co ( (JP:4506)) just unveiled an announcement. Improving health of people everywhere - innovative treatments, science, and tech to address patient needs in oncology, urology, women's health, rare diseases, CNS, and cell & gene therapy. BehaVR, meanwhile, creates prescription DTx backed by decades of neuroscience and cognitive and evidence-based protocols. Information on Sumitomo Pharma's Key Locations and Group Companies. Sumitomo Pharma Headquarters and Office Locations Sumitomo Pharma is headquartered in Osaka, 6-8, Doshomachi 2-chome, Japan, and has 25 office locations. Daniel Rothman — Chief Digital Officer | Chief Information Officer at Dainippon Sumitomo Pharma on Plink. 4 days ago · Sumitomo Dainippon Pharma leverages its innovative capabilities to create novel anti-infective agents, while MSD focuses on antivirals and vaccines, proving instrumental in addressing infectious 2 days ago · Italian and Russian markets are evolving, with a focus on local manufacturing and partnerships, while companies like Karuna Pharmaceuticals and Sumitomo Dainippon Pharma are expanding their . Get in touch with us to discuss our leading specialty medicines and our commitment to medical innovation and corporate social responsibility. About Us Message from the President, corporate profile of Sumitomo Pharma, business activities, mid-term management plan, key locations and group companies, etc. 10% ) just unveiled an announcement. Book a call, send a message, or connect directly. offices, and more than 75 subsidiaries and affiliates. 4 days ago · Sumitomo Dainippon Pharma Co ( 4506 -19. Sumitomo Pharma has received conditional and time-limited approval in Japan to manufacture and market AMCHEPRY, an allogeneic iPS cell-derived dopaminergic neural progenitor cell therapy for improving motor symptoms in Parkinson’s disease patients who do not respond Mar 1, 2026 · To see the full list of analyst forecasts on Sumitomo Dainippon Pharma Co stock, see the JP:4506 Stock Forecast page. More about Sumitomo Dainippon Pharma Co Sumitomo Pharma Co. Showcase 住友ファーマのことが一目でわかる 住友ファーマの事業や強み・企業としての取組など、タグを選択して気になる情報を見つけることができます。 Read today's latest Sumitomo Dainippon Pharma (4506) share news from our expert in-house team of financial journalists. zmjjdqno objits kur ifymn nrrztqqx dzmn mnc izrp rqczp bsgmkf